Why Third-Party Manufacturing Is Reshaping the Indian Pharma Industry in 2025
In India, Unimarck Pharma is a leader in third-party manufacturing, known for its WHO-GMP-certified infrastructure and stringent quality control systems. The company caters to startups and established pharma brands alike, manufacturing tablets, capsules, syrups, injectables, ointments, and more. Every batch is tested, approved, and delivered with precision.
With increasing demand for quality formulations and reduced timelines, third-party pharma manufacturing is rapidly becoming the backbone of the modern pharma business. Unimarck offers low MOQs, competitive pricing, and end-to-end services from formulation development to attractive packaging, making it an ideal partner for pharma brands aiming to scale without investing in infrastructure. In 2025 and beyond, third-party manufacturing isn’t just a trend; it’s a strategic advantage.
Comments
Post a Comment